Skip to main content
. 2022 Jan 26;20(5):782–793. doi: 10.1158/1541-7786.MCR-21-1037

Figure 4.

Figure 4. PGS predicted ADT response or clinical outcomes in independent hormone-naïve or CRPC clinical cohorts. A, Single-sample gene set enrichment score of PGS is proportionally related to the residual tumor volumes [RCB, r(35) = 0.74, P < 0.00001] in primary hormone-naïve prostate cancer treated with preoperative ADT (Sowalsky clinical cohort, n = 37). B, In the Sowalsky cohort, the PGS gene set enrichment score is significantly higher in nonresponders (NR) compared with exceptional responders (ER; P < 0.0001) and incomplete responders (IR; P < 0.0001). C and D, Kaplan–Meier estimate of OS or PFS segregated according to the PGS score in SU2C (A, n = 60) and Alumkal (B, n = 25) clinical cohorts. In both cohorts, patients with PGS = 1 had worse outcome than those with PGS = 0 (P = 0.0002 and 0.006, respectively). E, Panther Protein Classification of the PGS genes revealed that the genes were involved in various biological processes.

PGS predicted ADT response or clinical outcomes in independent hormone-naïve or CRPC clinical cohorts. A, Single-sample gene set enrichment score of PGS is proportionally related to the residual tumor volumes [RCB, r(35) = 0.74, P < 0.00001] in primary hormone-naïve prostate cancer treated with preoperative ADT (Sowalsky clinical cohort, n = 37). B, In the Sowalsky cohort, the PGS gene set enrichment score is significantly higher in nonresponders (NR) compared with exceptional responders (ER; P < 0.0001) and incomplete responders (IR; P < 0.0001). C and D, Kaplan–Meier estimate of OS or PFS segregated according to the PGS score in SU2C (A,n = 60) and Alumkal (B,n = 25) clinical cohorts. In both cohorts, patients with PGS = 1 had worse outcome than those with PGS = 0 (P = 0.0002 and 0.006, respectively). E, Panther Protein Classification of the PGS genes revealed that the genes were involved in various biological processes.